Yui Shibayama

753 citations
12 papers · 104 indexed · h-index 7
Topics
Hormonal Regulation and Hypertension (6 papers)Adrenal and Paraganglionic Tumors (5 papers)Diabetes Management and Research (3 papers)
Partner nations
JapanFranceSwitzerland

In The Last Decade

Yui Shibayama

12 papers receiving 102 citations

Peers

Yui Shibayama
Comparison fields: 5 of 28
  • Endocrinology, Diabetes and Metabolism 78
  • Surgery 68
  • Oncology 11
  • Epidemiology 8
  • Genetics 8
Replace Olga González Albarrán with:
Olga González Albarrán Spain
K Milek Germany
Michael Mitry Germany
Irina Bondar Russia
Masahiro Takihata Japan
James Smellie United Kingdom
Ken Yajima Japan
Aglaia Kyrilli Belgium
Leay Kiaw Er Taiwan
Maurício Teruo Tada Brazil
Yui Shibayama relative to Olga González Albarrán Spain Olga González Albarrán's profile →
Citations per field
00.5×
Olga González Albarrán · 1×
Citations per year

Countries citing papers authored by Yui Shibayama

Since Specialization
Citations

This map shows the geographic impact of Yui Shibayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yui Shibayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yui Shibayama more than expected).

Fields of papers citing papers by Yui Shibayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yui Shibayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yui Shibayama. The network helps show where Yui Shibayama may publish in the future.

Co-authorship network of co-authors of Yui Shibayama

This figure shows the co-authorship network connecting the top 25 collaborators of Yui Shibayama. A scholar is included among the top collaborators of Yui Shibayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yui Shibayama. Yui Shibayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 5
2 6
3 1
4 2
5 10
6 7
7 6
8 10
9 11
10 7
11 22
12 17

About Yui Shibayama

Yui Shibayama is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmaceutical Science and Surgery, having authored 12 papers that have together received 104 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (6 papers), Adrenal and Paraganglionic Tumors (5 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (78 citations), Surgery (68 citations) and Endocrine and Autonomic Systems (3 citations). Yui Shibayama has collaborated with scholars based in Japan, France and Switzerland. Frequent co-authors include Norio Wada, Tatsuya Atsumi, Akinobu Nakamura, Satoshi Terae, Hideaki Miyoshi, Hiraku Kameda, Mika Tsuiki, Mitsuhide Naruse, Kohei Kamemura and Yuichi Matsuda. Their work appears in journals such as Nature Cell Biology, Scientific Reports and Clinical Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026